Exponent abandons £1bn sale of UK accountancy group Xeinadin
A planned sale of UK accountancy firm Xeinadin has been shelved after Exponent failed to secure bids meeting its £1bn-plus valuation expectations, according to a report by the Financial Times. The UK buyout firm backed the business four years ago, and had appointed Evercore to run an auction last summer.